Backed by the NIH
Menopause-informed insights for better care
Amissa turns menopause symptoms and wearable data into visit-ready documentation that supports clinical decisions and efficient care delivery.
Perimenopause is clinically complex — and poorly documented
Real symptoms.
Incomplete documentation.
15%
of U.S. women have received a menopause diagnosis, highlighting how often symptoms go undocumented.
85%
of women experience symptoms that affect daily life.
1 in 5
women consider leaving work due to their symptoms.
$24b
in annual excess medical costs driven by delayed recognition and repeat visits.
We partner with patients and providers to close the documentation gap—turning symptoms into clinically useful data.
How Amissa Works
Amissa combines clinically useful symptom tracking with wearable data to create structured, longitudinal documentation for care teams.
Clinically grounded onboarding with the Menopause Rating Scale (MRS)
iOS and Android app captures menopause symptoms and wearable data
Identifies longitudinal trends and changes that matter for care decisions
Delivers EHR-ready documentation that fits existing clinical workflows
Amissa for providers
Clinical Benefits
Better clinical information → better decisions
Structured, longitudinal symptom tracking enables clinicians to:
Understand the severity, duration, and progression of menopause symptoms over time
Distinguish transient complaints from persistent clinical patterns
Identify symptom clusters that inform treatment decisions
Amissa for patients
Understanding & Validation
Helping patients communicate what they’re experiencing
Amissa collects patient-reported symptoms and wearable data to support more meaningful visits:
Less reliance on recalling months of symptoms during a short appointment
Clearer communication of what’s impacting daily life
Ongoing tracking that validates and documents the patient experience over time
Advancing Menopause Care Through Real-World Data
Amissa is designed as a research-enabled platform, developed to address gaps in women's health.
What this enables for researchers:
Validated clinical measures applied consistently across populations
Longitudinal real-world datasets supporting analysis, hypothesis generation, and discovery
Clinically grounded data capture aligned with routine care delivery
Trusted by Leading Organizations
Designed with Leaders in Women’s Health
Amissa is shaped by leading clinicians and researchers in midlife women’s health—ensuring our workflows, assessments, and insights align with real-world care.
Dr. Jaclyn Piasta
Monarch Health
Founder, Monarch Health Doctor of Nursing Practice Women’s Health Nurse Practitioner Certified Menopause Practitioner
Dr. Tara K. Iyer
Director, Menopause & Midlife Clinic, Brigham and Women’s Hospital
Brigham and Women’s Hospital; Instructor, Harvard Medical School
Dr. Emily Lau
Director, Women’s Heart Health Program
Massachusetts General Hospital, Assistant Professor of Medicine, Harvard Medical School
Dr. Aviva Stein
OB/GYN & Certified Menopause Practitioner, Atrium Health / Advocate Health
Atrium Health / Advocate Health
Dr. Ariel Haddad
Founder, Helia Health
OB/GYN & Certified Menopause Practitioner
Dr. Rebecca Thurston
Pittsburgh Foundation Chair in Women's Health and Dementia
Professor, departments of Psychiatry, Epidemiology, and Psychology, University of Pittsburg
Turn daily data into clinical insight.
Amissa makes it easier to deliver personalized, data-informed midlife care.